Molecular Characterization of Seminoma Utilizing the AACR Project GENIE: A Retrospective Observational Study
Cancers · 18.10.2025 · 17 (20) · 3363
DOI: 10.3390/cancers17203363 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 18.10.2025. Verfasst von Suchit R Geereddy und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Sciences, University of California-Davis, Davis, CA 95616, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Seminoma is a malignant germ cell tumor that most commonly involves the testicles but may involve the mediastinum, the retroperitoneum, and other extra-gonadal sites as well. This study aims to investigate the somatic genomic landscape of seminoma.
Methods
Data for a retrospective observational analysis of seminoma was acquired from the American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) with clinical and genomic data from 2017 and beyond. Using the R and R Studio software (R 4.5.0), analyses for common somatic mutations and copy number alterations were run with a statistical significance of p < 0.05.
Results
The most mutated genes included KIT (22.6%), KRAS (17.1%), and MTOR (5.1%), with significant copy number alterations in CDKN1B (17.2%), KRAS (14.7%), CCND2 (10.3%), and H3F3C (9.8%). These suggest involvement within the KIT/RAS/MAPK and PI3K/AKT/mTOR (PAM) pathways for seminoma development. A novel finding within comparative evaluation of PMS1 and AMER1 mutations were found in Black individuals. Additionally, our findings were consistent with a lower testicular cancer rate among individuals with African ancestry than European ancestry. BRD4 mutations were found only in metastatic samples while KMT2C, STAG2, ALK, AXL, and EGFR were only found in primary samples, suggesting a possible association.
Conclusions
This study provided a comprehensive molecular and genetic profiling of seminoma including key genetic alterations, affected pathways, and potential therapeutic strategies. Moreover, overlap between pathways and gene mutations provides the potential for alternative treatment options for seminoma via multiple pathways.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Biological Sciences, University of California-Davis, Davis, CA 95616, USA.
- College of Medicine, University of South Florida Health Morsani, Tampa, FL 33602, USA.
- College of Arts and Sciences, Santa Clara University, Santa Clara, CA 95053, USA.
- Department of Medicine, Arizona State University, Tempe, AZ 85281, USA.
- School of Medicine, Creighton University, Phoenix Campus, Phoenix, AZ 85012, USA.
- School of Medicine, Creighton University, Ohama Campus, Ohama, NE 68124, USA.
ORCID-Profile: Jonathan Lin, Akaash Surendra, Suraj Puvvadi
Zitieren
APA
Geereddy, S. R., Chang, A., Gallegos, A., Lin, J., Surendra, A., Puvvadi, S., Hsia, B., Tauseef, A., Thirumalareddy, J., & Sood, A. (2025). Molecular Characterization of Seminoma Utilizing the AACR Project GENIE: A Retrospective Observational Study. Cancers, 17(20), 3363. https://doi.org/10.3390/cancers17203363
Vancouver
Geereddy SR, Chang A, Gallegos A, Lin J, Surendra A, Puvvadi S, et al. Molecular Characterization of Seminoma Utilizing the AACR Project GENIE: A Retrospective Observational Study. Cancers. 2025;17(20):3363. doi:10.3390/cancers17203363
BibTeX
@article{Geereddy2025,
author = {Geereddy, Suchit R and Chang, Amber and Gallegos, Alma and Lin, Jonathan and Surendra, Akaash and Puvvadi, Suraj and Hsia, Beau and Tauseef, Abubakar and Thirumalareddy, Joseph and Sood, Akshat},
title = {Molecular Characterization of Seminoma Utilizing the AACR Project GENIE: A Retrospective Observational Study},
journal = {Cancers},
year = {2025},
volume = {17},
number = {20},
pages = {3363},
doi = {10.3390/cancers17203363}
}
EUVIMED